首页> 美国卫生研究院文献>Nucleic Acids Research >Comparison of effects of fostriecin novobiocin and camptothecin inhibitors of DNA topoisomerases on DNA replication and repair in human cells.
【2h】

Comparison of effects of fostriecin novobiocin and camptothecin inhibitors of DNA topoisomerases on DNA replication and repair in human cells.

机译:DNA拓扑异构酶抑制剂FostriecinNovobiocin和Camptothecin对人细胞中DNA复制和修复的作用比较。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fostriecin causes a delayed inhibition of replicative DNA synthesis in human cells, consistent with a role for DNA topoisomerase II (its target enzyme) at a late stage in replication. Fostriecin does not inhibit UV-induced excision repair. The less specific inhibitor novobiocin blocks repair in permeabilised cells given a low dose of UV, presumably through a mechanism other than the inhibition of topoisomerase II. Its effect cannot be accounted for by a depletion of the ATP required for incision. Camptothecin, an inhibitor of DNA topoisomerase I, blocks replicative DNA synthesis immediately but incompletely, suggesting a participation of topoisomerase I at the replication fork, but it, too, has no influence on DNA repair. We thus find no evidence for involvement of either topoisomerase I or II in the response of cells to UV damage.
机译:Fostriecin导致人细胞中复制性DNA合成的延迟抑制,这与复制后期DNA拓扑异构酶II(其靶标酶)的作用一致。福斯特霉素不抑制紫外线诱导的切除修复。特异性较低的抑制剂新霉素在低剂量的紫外线下会阻断透化细胞的修复,可能是通过抑制拓扑异构酶II以外的其他机制。切口所需的ATP耗竭无法解释其作用。喜树碱是DNA拓扑异构酶I的抑制剂,可立即但不完全阻断复制性DNA的合成,表明拓扑异构酶I参与复制叉,但对DNA修复也没有影响。因此,我们没有发现拓扑异构酶I或II参与细胞对UV损伤的反应的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号